Vaccine cocktail

The focus of this research is to see if a person can complete the immunisation course by receiving two distinct vaccine doses, one of Covishield and one of Covaxin. 

India plans to test a combination of its own Covid-19 vaccine, Covaxin, and a prospective intranasal vaccine developed by US researchers, in the hopes of boosting the two vaccines' protective effectiveness against the virus.